Sector portfolio · VC firm · United Kingdom
Oxford Science Enterprises' Biotech portfolio
Oxford Science Enterprises has backed 20 Biotech startups in rounds we track, $1.0B between them, shown by the stage each has reached. The best-funded is Beacon Therapeutics.
Oxford Science Enterprises's whole portfolioOxford Science Enterprises's profile
Funding by segment
- Series A$379M8
- Pre-seed and seed$67M6
- Series B$363M3
- Stage not reported$221M3
Where they are based
- United Kingdom18$970M
- Slovakia1$51M
United Kingdom
SlovakiaFounded
4 without a founding year on record.
Total raised
- Under $1M0
- $1M to $10M4
- $10M to $50M8
- $50M to $250M8
- $250M to $1B0
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
16 of 20 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United Kingdom18
- Slovakia1
Startups by country, 2 countries in all.
Segment by segment
Series A
8 startups · $379M raised
Alethio TherapeuticsAlethio Therapeutics is a preclinical-stage biotechnology company based in Abingdon Science Park near Oxford, UK.United Kingdom$98M
Nucleome TherapeuticsNucleome Therapeutics is a biotechnology company founded in 2019 and based in Oxford, United Kingdom.United Kingdom$66M
Sensible BiotechnologiesSensible Biotechnologies is a biotechnology company based in Boston, with additional locations in Oxford and Bratislava.Slovakia$51M
TheolyticsTheolytics is a clinical stage biotechnology company developing next-generation viral therapies.United Kingdom$48M
Kesmalea TherapeuticsKesmalea Therapeutics is a biotech startup focusing on the discovery of novel protein degraders.United Kingdom$38M
RefeynRefeyn is an innovative company founded in 2018 as a spinout from Oxford University, specializing in mass photometry.United Kingdom$30M- VVaccitechUnited Kingdom$28M
Oxford EndovascularOxford Endovascular are developing a novel treatment for treating brain aneurysms.United Kingdom$21M
Pre-seed and seed
6 startups · $67M raised
Vivid DxVivid Dx is a UK-based precision diagnostics company that specializes in the rapid detection of sepsis-causing pathogens and antimUnited Kingdom$19M- ODOrbit DiscoveryUnited Kingdom$17M
Scripta TherapeuticsScripta Therapeutics operates as a bio-tech company.United Kingdom$12M
DJS AntibodiesDJS Antibodies designs and discovers novel therapeutic monoclonal antibodies against GPCRs.-$8.0M
AlethiomicsAlethiomics is a biotech company harnessing the power of single-cell multi-omic technology to discover & develop treatment for blood cancer.United Kingdom$8.0M- CCaristoUnited Kingdom$3.1M
Series B
3 startups · $363M raised
Greywolf TherapeuticsGreywolf Therapeutics is a clinical-stage biotechnology company based in Oxford, United Kingdom.United Kingdom$144M
MiroBioMiroBio is Harnessing the natural control mechanisms of the immune system.United Kingdom$144M- OONIONI is a marketing agency that offers services in printing, SEA, SEO, and social network platforms.United Kingdom$75M
Stage not reported
3 startups · $221M raised
PepgenPepGen is empowering nucleic acid therapeutics to go the distance.United Kingdom$115M
Amber TherapeuticsAmber Therapeutics is a clinical-stage medical technology company based in London, founded in 2021 as a spinout from the UniversitUnited Kingdom$102M
SpyBiotechSpyBiotech Operators of a biotechnology platform intended to generate next-generation vaccines.United Kingdom$4.1M
How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Oxford Science Enterprises as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosRaising from investors like Oxford Science Enterprises?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.